FDA Warns Consumers About Tainted Weight Loss Pills
Agency seeks recall of products that pose serious health 
riskshttp://www.fda.gov/bbs/topics/NEWS/2008/NEW01933.html 
                

The U.S. Food and Drug Administration is alerting consumers nationwide not
  to purchase or consume more than 25 different products marketed for weight
  loss because they contain undeclared, active pharmaceutical ingredients that
may put consumers’ health at risk. 


The tainted weight loss products are:

  
    
Fatloss Slimming
    
2 Day Diet      
    
3x Slimming Power
  
  
    Japan Lingzhi  24 Hours Diet
    5x Imelda Perfect Slimming
    3 Day Diet 
  
  
    7 Day Herbal Slim
    8 Factor Diet
    7 Diet Day/Night Formula
  
  
    999 Fitness Essence
    Extrim Plus
    GMP
  
  
    Imelda Perfect Slim
    Lida DaiDaihua
    Miaozi Slim Capsules
  
  
    Perfect Slim
    Perfect Slim 5x
    Phyto Shape
  
  
    ProSlim Plus
    Royal Slimming Formula
    Slim 3 in 1
  
  
    Slim Express 360
    Slimtech
    Somotrim
  
  
    Superslim
    TripleSlim
    Zhen de Shou
  
  
    Venom Hyperdrive 3.0
     
     
  



An FDA analysis found that the undeclared active pharmaceutical ingredients
  in some of these products include sibutramine (a controlled substance), 
rimonabant
  (a drug not approved for marketing in the United States), phenytoin (an 
anti-seizure
  medication), and phenolphthalein (a
  solution used in chemical experiments and a suspected cancer causing agent).
  Some of the amounts of active pharmaceutical ingredients far exceeded the 
FDA-recommended
levels, putting consumers' health at risk.
These weight loss products, some of which are marketed as  “dietary
  supplements,” are promoted and sold on various Web sites and in some
  retail stores. Some of the products claim to be “natural” or to
  contain only  “herbal” ingredients, but actually contain potentially
  harmful ingredients not listed on the product labels or in promotional 
advertisements.
  These products have not been approved by the FDA, are illegal and may be 
potentially
  harmful to unsuspecting consumers.  
The FDA advises consumers who have used any of these products to stop taking
  them and consult their healthcare professional immediately. The FDA encourages
  consumers to seek guidance from a healthcare professional before purchasing
  weight loss products.  
“These tainted weight loss products pose a great risk to public health
  because they contain undeclared ingredients and, in some cases, contain 
prescription
  drugs in amounts that greatly exceed their maximum recommended dosages,” said
  Janet Woodcock, M.D., director, Center for Drug Evaluation and Research, FDA. 
“Consumers
  have no way of knowing that these products contain powerful drugs that could
  cause serious health consequences. Therefore FDA is taking this action to 
protect
  the health of the American public.”
The FDA has inspected a number of companies associated with the sale of these
  illegal products, and is currently seeking product recalls. Based on the FDA’s
  inspections and the companies’ inadequate responses to recall requests,
  the FDA may take additional enforcement steps, such as issuing warning letters
  or initiating seizures, injunctions, or criminal charges. 
The health risks posed by these products can be serious; for example, 
sibutramine,
  which was found in many of the products, can cause high blood pressure, 
seizures,
  tachycardia, palpitations, heart attack or stroke. This drug can also interact
  with other medications that patients may be taking and increase their risk
  of adverse drug events. The safety of sibutramine has also not been 
established
  in pregnant and lactating women, or in children younger than 16 years of age. 
Rimonabant, another ingredient found in these products, was evaluated, but
  not approved by the FDA for marketing in the United States. The drug, which
  is approved in Europe, has been associated with increased risk of depression
  and suicidal thoughts and has been linked to five deaths and 720 adverse 
reactions
  in Europe over the last two years. 

   

  Health care professionals and consumers should report serious adverse events
  (side effects) or product quality problems to the FDA’s MedWatch Adverse
  Event Reporting program either online, by regular mail, fax or phone. 
Online: www.fda.gov/MedWatch/report.htmRegular Mail: use postage-paid FDA form 
3500 available at: www.fda.gov/MedWatch/getforms.htm
    and mail to MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787 Fax: 
(800) FDA-0178 Phone: (800) FDA-1088
Information for consumers can be found at:

    http://www.fda.gov/cder/consumerinfo/weight_loss_products.htm
  To learn more about FDA’s initiative against unapproved drugs read FDA’s
  Compliance Policy Guide here: http://www.fda.gov/cder/Guidance/6911fnl.htm. 
  For drug safety information, read: FDA's
    Drug Safety Initiative


      

Kirim email ke